GlobeNewswire
Zevra Therapeutics, Inc. Appoints Alicia Secor to Board of Directors; Announces Retirement of Wendy Dixon, PhD
📈
AI Sentiment
Highly Positive
8/10
- Home
- ZVRA
as of 12-04-2025 3:46pm EST
$8.65
$0.08
-0.86%
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.
Chart Type:
Time Range:
| Founded: | 2006 | Country: | United States |
| Employees: | N/A | City: | CELEBRATION |
| Market Cap: | 499.9M | IPO Year: | 2015 |
| Target Price: | $21.71 | AVG Volume (30 days): | 1.4M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.54 | EPS Growth: | N/A |
| 52 Week Low/High: | $6.19 - $13.16 | Next Earning Date: | 11-05-2025 |
| Revenue: | $84,388,000 | Revenue Growth: | 244.60% |
| Revenue Growth (this year): | 336.43% | Revenue Growth (next year): | 54.26% |
AI-Powered ZVRA Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated a day ago
AI Recommendation
hold
Model Accuracy: 70.43%
70.43%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of Zevra Therapeutics Inc. (ZVRA)
Shih Alvin
Buy
Director
ZVRA Sep 12, 2025
Avg Cost/Share
$7.89
Shares
20,000
Total Value
$157,800.00
Owned After
20,000
SEC Form 4
FAVORITO TAMARA A
Buy
Director
ZVRA Sep 12, 2025
Avg Cost/Share
$7.79
Shares
3,175
Total Value
$24,718.01
Owned After
3,894
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Shih Alvin | ZVRA | Director | Sep 12, 2025 | Buy | $7.89 | 20,000 | $157,800.00 | 20,000 | |
| FAVORITO TAMARA A | ZVRA | Director | Sep 12, 2025 | Buy | $7.79 | 3,175 | $24,718.01 | 3,894 |
Latest Zevra Therapeutics Inc. News
ZVRA Breaking Stock News: Dive into ZVRA Ticker-Specific Updates for Smart Investing
Compare ZVRA vs Leading Stocks
See how ZVRA stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "ZVRA Zevra Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.